3630 results for «294»
3630 results
TAVI for pure aortic regurgitation with a dedicated CE-mark device: an underdiagnosed and undertreated disease
26 Nov 2024 – From PCR London Valves 2024
Explore this session to learn about the unmet needs in aortic regurgitation (AR) and the performance of dedicated TAVI devices for AR. Discover why new thresholds for severe AR are necessary, and how traditional methods may underestimate its severity. Gain insights into the TRILOGY THV system,...
From index procedure to re-valving with a novel self-expanding valve
25 Nov 2024 – From PCR London Valves 2024
Watch this simulation-based symposium to explore the value of the Index Procedure in achieving optimal outcomes during the initial implant, crucial for preventing paravalvular leak, pacemaker dependency, and ensuring precise commissural alignment for coronary access. Discover how the ACURATE neo2/PRIME offers excellent coronary access with its...
Transforming interventional care for patients with mitral regurgitation: simulation and case-based learning
26 Nov 2024 – From PCR London Valves 2024
Explore the differentiating features of the PASCAL Precision system for the treatment of patients with mitral regurgitation through simulation and case-based learning.
Pushing the boundaries to optimise patient outcomes: from planning to success
26 Nov 2024 – From PCR London Valves 2024
Learn from experts about achieving optimal TAVI outcomes, tailoring approaches for lifetime management, and mastering tips for diverse anatomical challenges.
Zero-contrast TAVI while using a novel full-body embolic protection filter
26 Nov 2024 – From PCR London Valves 2024
Discover the latest advancements in zero-contrast TAVI through this case-based session. Learn when to consider a zero-contrast protocol, gain practical insights on performing the procedure, and explore a novel full-body embolic protection filter designed to enhance safety during transcatheter interventions.
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
Leading innovation for patients with valvular heart disease
24 Nov 2024 – From PCR London Valves 2024
Discover the newest advancements in transcatheter heart valves and their role in modern lifetime management of valvular heart disease. Review the latest clinical outcomes demonstrating improved patient care and explore how a diverse device portfolio addresses a wide range of valve anatomies.
Rendez-vous with Myval THV series and Landmark RCT subset analysis
24 Nov 2024 – From PCR London Valves 2024
Discover this interactive session during which the audience learns about and discusses the novel Myval THV Series, a series of valves featuring intermediate and XL sizes. They also discuss the results of the pivotal LANDMARK randomized controlled trial and its relevance in clinical practice.
Optimisation of your valve implantation to ensure lifelong outcomes using a novel self-expanding valve
24 Nov 2024 – From PCR London Valves 2024
Gain insights into the importance of valve optimization post-implantation to secure acute and long-term outcomes. In this session, you will discover the new features and benefits of the ACURATE Prime platform illustrated by a recorded case, and compare how different TAVI platforms perform when treating larger...
Innovation never stops: Cardiovalve in action!
24 Nov 2024 – From PCR London Valves 2024
Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.
Tailored techniques for left main bfurcation interventions
16 May 2024 – From EuroPCR 2024
This session explores various techniques and strategies for managing complex left main bifurcation lesions. It features case studies that demonstrate the use of hybrid PCI to reduce metal burden, the importance of IVUS guidance, the challenges of large dimension left main PCI, and the role of...
Which techniques to improve results of PCI in calcified lesions
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on techniques to improve PCI outcomes in calcified lesions. It covers various case presentations and discussions, including the use of imaging to guide therapy for calcified noduli, planning strategies for tortuous and calcified lesions, managing balloon-undilatable...
Drug coated balloon PCI in complex scenarios
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on the use of drug-coated balloons (DCB) in complex PCI scenarios. It covers various case presentations and discussions, including the use of DCB in left main PCI, 2-year angiographic follow-up after left anterior descending artery PCI...
Bridging perspectives: bifurcation lesions - A global case exploration
16 May 2024 – From EuroPCR 2024
This session explores the management of bifurcation lesions from a global perspective, featuring case studies and discussions from experts in various regions. The session covers topics such as when to use two stents for bifurcation lesions, techniques for managing complicated Medina 0,0,1 bifurcation lesions, and the...
New data on TAVI
16 May 2024 – From EuroPCR 2024
This session presents the latest research and data on transcatheter aortic valve implantation (TAVI). It covers a range of topics, including long-term results of TAVI versus surgical aortic valve replacement in low-risk severe aortic stenosis, real-world experience with novel transcatheter heart valve devices, outcomes in patients...
How to obtain the best PCI results in calcified lesions
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore various strategies and techniques for achieving optimal PCI outcomes in patients with calcified coronary lesions. Participants will learn about plaque modification approaches, the use of IVUS guidance, and innovative ways to overcome the challenges posed by heavily...
TAVI indications: real dilemmas
16 May 2024 – From EuroPCR 2024
This session comprises selected clinical case submissions that explore real-world dilemmas and challenges faced by interventional cardiologists in TAVI procedures. Participants will delve into discussions on topics such as left bundle branch area pacing after TAVR, challenges in TAVI, simultaneous CardioFlow Optimisation, coronary access post-TAVI, complex...
Management of LAA closure complications
16 May 2024 – From EuroPCR 2024
This session explores the various complications that can arise during left atrial appendage (LAA) closure procedures, including pericardial effusion, device embolisation, and procedural strokes. Learn how to identify risk factors, prevent these complications, and effectively manage them through case-based discussions and expert guidance.
Challenging LAA occlusion cases
16 May 2024 – From EuroPCR 2024
This session features selected clinical case submissions that explore complex and challenging scenarios in left atrial appendage (LAA) occlusion procedures. Participants will learn about techniques for rescuing a migrating LAA occluder, managing incomplete surgical LAA ligation, and utilizing specialized techniques like the "kissing" approach for LAA...
Vulnerable plaque identification and treatment
16 May 2024 – From EuroPCR 2024
This session focuses on the role of non-invasive and intra-coronary imaging in the identification and management of vulnerable plaque. Participants will explore the use of CCTA and intracoronary imaging techniques, such as IVUS, to diagnose vulnerable atherosclerosis. The session also evaluates the evidence supporting conservative or...
